1. Home
  2. LINC vs CTMX Comparison

LINC vs CTMX Comparison

Compare LINC & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

HOLD

Current Price

$21.77

Market Cap

732.0M

Sector

Real Estate

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.87

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINC
CTMX
Founded
1946
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
732.0M
596.2M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
LINC
CTMX
Price
$21.77
$3.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$26.67
$6.50
AVG Volume (30 Days)
261.2K
2.9M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
40.12
50.22
EPS
0.45
0.24
Revenue
$494,742,000.00
$113,631,000.00
Revenue This Year
$17.79
N/A
Revenue Next Year
$9.23
N/A
P/E Ratio
$49.71
$16.49
Revenue Growth
16.90
N/A
52 Week Low
$14.10
$0.40
52 Week High
$25.76
$4.62

Technical Indicators

Market Signals
Indicator
LINC
CTMX
Relative Strength Index (RSI) 55.57 52.13
Support Level $20.25 $3.66
Resistance Level $22.71 $4.20
Average True Range (ATR) 0.96 0.25
MACD 0.24 -0.03
Stochastic Oscillator 74.50 58.01

Price Performance

Historical Comparison
LINC
CTMX

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: